The Hair Shedding Visual Scale: A Quick Tool to Assess Hair Loss in Women

Martínez‐Velasco, María Abril; Vázquez-Herrera, Norma Elizabeth; Maddy, Austin J.; Asz-Sigall, Daniel; Tosti, Antonella

doi:10.1007/s13555-017-0171-8

Cited by 19 publications

(11 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In order to evaluate the extent of TE, a visual analogic scale (VAS) was used for thick hair length (shoulder, mid-back) by dividing a bundle of hairs of each patient into nine piles of increasing hair amount (10, 50, 100, 200, 300, 400, 500, 600 and 700 hairs) as previously described by Martinez-Velasco MA et al. [ 12 ].…”

Section: Methodsmentioning

confidence: 99%

Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia

et al. 2022

View full text Add to dashboard Cite

Background: A higher risk for COVID-19 infection and severity for men compared to women has been described since the beginning of the pandemic. The role of androgens has been recently highlighted as they control two key steps of coronavirus infection mediated through the transmembrane protease serin 2 (TMPRRS2) and the angiotensin-converting enzyme 2 (ACE2) receptor in the lung tissue. Furthermore, a high incidence of androgenic alopecia among males with COVID-19 disease have been reported. Objective: This study aims to evaluate the telogen effluvium (TE) prevalence and its relationship with clinical and immunologic parameters in a sample of patients consecutively evaluated after recovery from COVID-19 pneumonia in Northern Italy. Methods: Overall 104 patients were recruited within three months from COVID-19 pneumonia recovery; 80 (77%) had been hospitalized in a Respiratory Intensive Care Unit and the remaining ones had been treated at home. The extent of TE was assessed with a visual analogic scale for thick bundle of hairs. Demographic and clinical data and systemic inflammation biomarkers were also evaluated. Results. Thirty-two patients reported a history of TE and their mean TE-VAS score was 5.78 ± 1.72 (range 3–9). Women had about a 5-fold higher risk (odds) of complaining of TE compared to males (OR = 4.69, 95%CI: 1.91, 11.49; p = .001), and the association became stronger when adjusted for COVID-19 severity (hospital admission vs home care: OR = 6.09, 95%CI: 2.34, 15.88; p < .001). Levels of C-reactive protein >1.90 mg/l (OR adj : 2.43, 95%CI 0.85, 7.05, p = 0.096) or IL 1β > 5 ng/l (OR adj 4.72, 95%CI: 1.31, 23.19, p = .03) were also significantly associated with TE. Conclusion: This exploratory study raises the hypothesis that hair shedding is more strictly related to the severity of COVID-19 disease and the underlying inflammation rather than to patients' hormonal status. KEY MESSAGES The presence of Telogen effluvium (TE) was significantly more common in women. Higher severity of the Covid-19 disease seems to play a critical role, more important than the hormonal influence, in the development of TE. The severity of inflammation related to TE and Covid-19 could also play a role as suggested by the higher levels of CRP and platelets and IL1β.

show abstract

Section: Methodsmentioning

confidence: 99%

Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Primary efficacy assessments included investigator and patient assessment of degree of hair shedding based on a 10-point visual analog scale relating to the patient's hair type and length (short, medium, or long) [10], hair mass index (HMI) assessed by trichometry, and photographic evaluation. Patients were instructed to collect and bring to visit the hair shed during a shampoo before starting the study and before the 3-and 6-month follow-up visits.…”

Section: Methodsmentioning

confidence: 99%

Effects of a New Topical Treatment Containing Several Hair Growth Promoters in Women with Early Female Pattern Hair Loss

Vincenzi

Marisaldi

Tosti

et al. 2018

Skin Appendage Disord

Self Cite

View full text Add to dashboard Cite

Background: Female pattern hair loss (FPHL) is increasing ly common and often presents with hair shedding. Spec tral.DNC-N® contains anti-inflammatory actives and hair growth promoters. Objectives: To assess the efficacy and tolerability of Spectral DNC-N® (DS Laboratories, Inc.) in women with early FPHL and excessive shedding. Methods: Forty-nine patients were treated with Spectral DNC-N®, applied twice daily for 3 months; 28 patients were included in the 3-month treatment extension. Efficacy assessments included the degree of hair shedding using the validated hair shedding visual scale, hair mass index (HMI), and photographic evaluation. Results: There was a statistically significant decrease in hair shedding and a corresponding increase in HMI by month 3, which was maintained through month 6. The mean investigator-assessed hair shedding score decreased from 3.5 to 2.0 and the hair mass increased from 75.8 to 84.3 mm²/cm² by month 3 (both p < 0.01 compared with baseline). By month 6, the hair shedding score was reduced to 1.6 and the hair mass was maintained. Most patients (75%) showed an increase in global hair density. Conclusions: Spectral.DNC-N® significantly reduced hair shedding, with a corresponding increase in hair mass and density. These effects were already evident after 3 months’ treatment and further improved in those patients who continued treatment to month 6. Tolerability was good and patient satisfaction levels were high.

show abstract

“…Existem várias formas de quantificar a queda de cabelo, algumas já previamente mencionadas. 45 O teste de lavagem modificado definido por Rebora 1, 46 continua atual e permite, além da confirmação e quantificação da queda, distinguir a AAG do DTC. Este baseia-se no facto do número de cabelos velos (por definição, com < 3 cm) ser superior na AAG, e do deflúvio ser maior no DTC.…”

Section: Teste De Lavagem (Original Ou Modificado/ Simplificado)unclassified

Deflúvio Telogénico Crónico

Calvão¹,

Soares²

2020

SPDV

View full text Add to dashboard Cite

O deflúvio telogénico crónico pode definir-se como uma queda de fios superior à fisiológica (acima de 150-200 fios/dia) por um período superior a seis meses, sem que exista uma causa evidente. Embora comum, é muitas vezes subdiagnosticado, e levanta várias questões de índole prática às quais a literatura tem dificuldade em responder, desde a sua etiopatogénese à terapêutica. Neste artigo da Educação Médica Contínua, pretendemos ajudar a responder a estas questões, revendo a definição, fisiopatologia, caraterísticas clínicas / tricoscópicas / histológicas e a terapêutica do deflúvio telogénico crónico.

show abstract

The Hair Shedding Visual Scale: A Quick Tool to Assess Hair Loss in Women

Cited by 19 publications

References 22 publications

Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia

Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia

Effects of a New Topical Treatment Containing Several Hair Growth Promoters in Women with Early Female Pattern Hair Loss

Deflúvio Telogénico Crónico

Contact Info

Product

Resources

About